Literature DB >> 2840634

Tissue specific sequence motifs in the enhancer of the leukaemogenic mouse retrovirus SL3-3.

B Hallberg1, T Grundström.   

Abstract

The long terminal repeat (LTR) of the retrovirus SL3-3 determines its tropism for T-lymphocytes and its ability to induce T-cell lymphomas in mice. We have studied the ability of different DNA sequences located upstream of the "TATA" box in the LTR of SL3-3 to enhance transcription in T-lymphocyte cell lines and other cell lines, employing a transient assay and quantitative S1 nuclease mapping. The enhancer was found to be composed of many DNA domains which determines different activities in different cell lines. We find enhancer sequence motifs with a high T-lymphocyte specificity in the DNA repetitions of the LTR, and other enhancer motifs active in a broader range of cells in the surrounding DNA segments. The localization of sequences preferentially active in T-cells within the repeated sequences containing differences between SL3-3 and the very closely related Akv virus, which is without the T cell tropism and leukaemogenicity of SL3-3, supports the notion that the enhancer sequence motifs with T-cell preferences are primary determinants of these properties.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840634      PMCID: PMC336838          DOI: 10.1093/nar/16.13.5927

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Requirement of stereospecific alignments for initiation from the simian virus 40 early promoter.

Authors:  K Takahashi; M Vigneron; H Matthes; A Wildeman; M Zenke; P Chambon
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

3.  The structure of an oligo(dA).oligo(dT) tract and its biological implications.

Authors:  H C Nelson; J T Finch; B F Luisi; A Klug
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

4.  Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3.

Authors:  A Thornell; B Hallberg; T Grundström
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

5.  Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene.

Authors:  H M Jantzen; U Strähle; B Gloss; F Stewart; W Schmid; M Boshart; R Miksicek; G Schütz
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

6.  Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour.

Authors:  F S Pedersen; R L Crowther; D Y Tenney; A M Reimold; W A Haseltine
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

7.  New versatile cloning and sequencing vectors based on bacteriophage M13.

Authors:  M P Kieny; R Lathe; J P Lecocq
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

8.  Hybrid cell line from a cloned immunoglobulin-producing mouse myeloma and a nonproducing mouse lymphoma.

Authors:  B Mohit; K Fan
Journal:  Science       Date:  1971-01-08       Impact factor: 47.728

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  16 in total

1.  Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers.

Authors:  B Corneliussen; A Thornell; B Hallberg; T Grundström
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.

Authors:  B Hallberg; J Schmidt; A Luz; F S Pedersen; T Grundström
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Authors:  S Ethelberg; J Lovmand; J Schmidt; A Luz; F S Pedersen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.

Authors:  H L Morrison; H Y Dai; F S Pedersen; J Lenz
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

5.  Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.

Authors:  Ditte Ejegod; Karina Dalsgaard Sørensen; Ilona Mossbrugger; Leticia Quintanilla-Martinez; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

6.  Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences.

Authors:  A Thornell; B Hallberg; T Grundström
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences.

Authors:  S Lovmand; N O Kjeldgaard; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  DNA-binding proteins that interact with the long terminal repeat of radiation leukemia virus.

Authors:  I Gorska-Flipot; P Jolicoeur
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

9.  Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.

Authors:  A L Zaiman; J Lenz
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

10.  Mutant analysis of protein interactions with a nuclear factor I binding site in the SL3-3 virus enhancer.

Authors:  P Nilsson; B Hallberg; A Thornell; T Grundström
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.